secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZYNEX INC (—)
CIK:        0000846475
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001104659-26-035274
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.02, 2.03, 3.02, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zynex emerges from Chapter 11; all common stock canceled, $10M exit loan, new board
--------------------------------------------------------------------------------

- Old common stock canceled; Plan Sponsor Altivera Medical Holdings receives 100% of 1,000 new shares.
- Exit Credit Agreement provides $10.0M senior secured term loan due 2034, convertible to common stock.
- DIP facility ($22.3M) and $60M 5% Convertible Senior Notes discharged on Effective Date.
- New board: Vikram Bajaj and John Bibb as directors; officers remain in same capacities.
- Articles amended to authorize 1M shares of $0.001 par common stock, no other classes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/846475/000110465926035274/0001104659-26-035274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/846475/000110465926035274/zyxi-20260326x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-035274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer